Pharma - Features – 06 November 2018
On 1 November, cannabis-based epilepsy treatment Epidiolex went on sale throughout the US, having become the first drug incorporating non-synthetic cannabidiol to win FDA approval over the summer. In our latest in-house Q&A, PLN caught up with Epidiolex manufacturer GW Pharmaceutical’s general counsel Iain Ward.
Pharma - Features – 18 September 2018
As part of our ongoing series of interviews with in-house lawyers at international pharma companies, PLN caught up with Stathis Mihos – Pfizer’s legal director and Greece, Cyprus, Malta, Israel and Adriatic sub-cluster lead – to discuss the challenges of doing business in the region and the company’s unique approach to working with outside counsel.
Pharma - Features – 04 September 2018
In the first of a new occasional series of interviews, PLN speaks to Merck’s general counsel for Latin America Alejandro Torrendell about in-house life at a pharma company in the region and how his department stays ahead of the curve.
Pharma - Features – 17 July 2018
The American Bar Association’s Section of International Law hosted its 2018 Life Sciences Conference in Copenhagen last month, including, among other sessions, a detailed panel discussion of drug pricing practices around the world.
Pharma - Features – 10 July 2018
Drug pricing is a “pivotal point” for the pharmaceuticals industry, where the high cost of innovation often comes into conflict with the political drive to keep prices down, according to an array of international speakers who offered local snapshots of recent developments at a conference held by the American Bar Association’s Section of International Law in Copenhagen last month.
Pharma - Features – 12 June 2018
The American Bar Association’s Section of International Law opened its 2018 life sciences conference in Copenhagen on 11 June with discussions of how big data, and its regulation in Europe under the new General Data Protection Regulation (GDPR), is driving change and disruption in the industry